𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Immunotherapy for head and neck cancer

✍ Scribed by Annie A. Wu; Kevin J. Niparko; Sara I. Pai

Publisher
BioMed Central
Year
2008
Tongue
English
Weight
314 KB
Volume
15
Category
Article
ISSN
1021-7770

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Characterization of a spontaneously aris
Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy
✍ Dianne Khurana; Elizabeth A. Martin; Jan L. Kasperbauer; Bert W. O'Malley Jr; Di πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 237 KB πŸ‘ 1 views

## Abstract ## Background To develop novel therapeutic approaches for patients with head and neck malignancies, poorly immunogenic murine models of squamous cell carcinoma (SCC) need to be defined. ## Methods The phenotype, growth characteristics, and responsiveness to tumor‐specific T‐cell tran

Gene therapy for head and neck cancer
Gene therapy for head and neck cancer
✍ Dr. Gary L. Clayman πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 733 KB

Background. Molecular or gene therapy involves the introduction of genetic material (DNA) into host cells to induce the expression of the therapeutic product of that gene. This ability to transfer genetic material provides a novel approach for the investigation and potential treatment of a variety o

Novel neoadjuvant immunotherapy regimen
Novel neoadjuvant immunotherapy regimen safety and survival in head and neck squamous cell cancer
✍ Gregory T. Wolf; Willard E. Fee Jr; Robert W. Dolan; Jeffrey S. Moyer; Michael J πŸ“‚ Article πŸ“… 2011 πŸ› John Wiley and Sons 🌐 English βš– 1016 KB

## Abstract ## Background Cellular immune suppression is observed in head and neck squamous cell cancer (HNSCC) and contributes to poor prognosis. Restoration of immune homeostasis may require primary cell‐derived cytokines at physiologic doses. An immunotherapy regimen containing a biologic, with